✦ LIBER ✦

Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid

✍ Scribed by Christopher W. Ryan; Dezheng Huo; Kathryn Bylow; Laurence M. Demers; Walter M. Stadler; Tara O. Henderson; Nicholas J. Vogelzang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined use of zoledronic acid and 153S

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB

Zoledronic acid to prevent bone loss in

✍ Chi-hang YEE; Chi-fai NG; Annie YF WONG; Chi-kowk CHAN; See-ming HOU; Sidney KH 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

The risk of renal impairment in hormone-

✍ William K. Oh; Kevin Proctor; Mari Nakabayashi; Carolyn Evan; Lauren K. Tormey; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Preserving bone health in patients with

✍ Fred Saad; Per-Anders Abrahamsson; Kurt Miller 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Effect of zoledronic acid on markers of

✍ Vassilios Perifanis; Timoleon Vyzantiadis; Konstantinos Tziomalos; Sofia Vakalop 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 171 KB

Additive effect of zoledronic acid on se

✍ Naoto Kamiya; Hiroyoshi Suzuki; Takumi Endo; Makoto Takano; Masashi Yano; Makito 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB